文献速递认知障碍与痴呆帕金森病与运动障碍

孤立性快速眼动睡眠行为障碍患者临床进展相关的99mTc-HMPAO SPECT灌注特征

99mTc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder.
PubMed 文献 · Neurology · 2024-02-05

本研究对52例孤立性快速眼动睡眠行为障碍(iRBD)患者进行基线99mTc-HMPAO SPECT检查,用偏最小二乘相关分析提取与27项临床特征相关的灌注潜变量。47例纵向随访4.5年,12例(26%)转化为突触核蛋白病(4例痴呆伴路易体,8例帕金森病)。第二个潜变量与转化为痴呆伴路易体相关。

要点

  • iRBD患者基线SPECT灌注模式中,第二个潜变量与认知特征及RBD病程相关,并与转化为痴呆伴路易体相关。
  • 47例iRBD纵向随访4.5年,12例(26%)转化为突触核蛋白病,其中4例痴呆伴路易体、8例帕金森病。
  • 第一个潜变量与运动、认知、感知变量及年龄、性别相关,并与转化为突触核蛋白病相关。

核心结论

  • 本研究识别出与iRBD认知损害及转化为痴呆伴路易体相关的脑灌注特征,该特征可从个体扫描中提取,有潜力发展为预测高危个体痴呆伴路易体的生物标志物。

研究设计与样本

  • iRBD患者接受视频多导睡眠监测、神经科及神经心理学评估和基线99mTc-HMPAO SPECT检查,用偏最小二乘相关分析识别潜变量。
  • 共137例参与者,93例完成SPECT处理:52例iRBD患者(67.9岁,73%男性)、19例帕金森病患者(67.3岁,37%男性)、22例健康对照(67.0岁,73%男性)。
  • 47例iRBD患者纵向随访4.5年;另对24例iRBD患者进行第二次灌注扫描,并评估22例健康对照和19例帕金森病患者的特征表达。

主要发现

  • 47例纵向随访的iRBD患者中,12例(26%)转化为突触核蛋白病,包括4例痴呆伴路易体和8例帕金森病。
  • 分析得出两个潜变量:第一个与运动、认知、感知变量及年龄、性别等广泛特征相关;第二个主要与认知特征和RBD病程相关。
  • 第一个潜变量的表达与转化为突触核蛋白病相关,第二个潜变量的表达与转化为痴呆伴路易体相关。
  • 这些模式的表达随时间变化,并与更差的运动特征相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Idiopathic/isolated REM sleep behavior disorder (iRBD) is associated with dementia with Lewy bodies and Parkinson disease. Despite evidence of abnormal cerebral perfusion in iRBD, there is currently no pattern that can predict whether an individual will develop dementia with Lewy bodies or Parkinson disease. The objective was to identify a perfusion signature associated with conversion to dementia with Lewy bodies in iRBD. METHODS: Patients with iRBD underwent video-polysomnography, neurologic and neuropsychological assessments, and baseline 99mTc-HMPAO SPECT to assess relative cerebral blood flow. Partial least squares correlation was used to identify latent variables that maximized covariance between 27 clinical features and relative gray matter perfusion. Patient-specific scores on the latent variables were used to test the association with conversion to dementia with Lewy bodies compared with that with Parkinson disease. The signature's expression was also assessed in 24 patients with iRBD who underwent a second perfusion scan, 22 healthy controls, and 19 individuals with Parkinson disease. RESULTS: Of the 137 participants, 93 underwent SPECT processing, namely 52 patients with iRBD (67.9 years, 73% men), 19 patients with Parkinson disease (67.3 years, 37% men), and 22 controls (67.0 years, 73% men). Of the 47 patients with iRBD followed up longitudinally (4.5 years), 12 (26%) developed a manifest synucleinopathy (4 dementia with Lewy bodies and 8 Parkinson disease). Analysis revealed 2 latent variables between relative blood flow and clinical features: the first was associated with a broad set of features that included motor, cognitive, and perceptual variables, age, and sex; the second was mostly associated with cognitive features and RBD duration. When brought back into the patient's space, the expression of the first variable was associated with conversion to a manifest synucleinopathy, whereas the second was associated with conversion to dementia with Lewy bodies. The expression of the patterns changed over time and was associated with worse motor features. DISCUSSION: This study identified a brain perfusion signature associated with cognitive impairment in iRBD and transition to dementia with Lewy bodies. This signature, which can be derived from individual scans, has the potential to be developed into a biomarker that predicts dementia with Lewy bodies in at-risk individuals.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rahayel S, Postuma R, Baril AA, et al. 99mTc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder. Neurology. 2024. PMID: 38315966. doi:10.1212/WNL.0000000000208015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。